MX9304187A - HEMATOPOYETIC FACILITATORY CELLS. - Google Patents
HEMATOPOYETIC FACILITATORY CELLS.Info
- Publication number
- MX9304187A MX9304187A MX9304187A MX9304187A MX9304187A MX 9304187 A MX9304187 A MX 9304187A MX 9304187 A MX9304187 A MX 9304187A MX 9304187 A MX9304187 A MX 9304187A MX 9304187 A MX9304187 A MX 9304187A
- Authority
- MX
- Mexico
- Prior art keywords
- cells
- hematopoietic
- facilitator
- bone marrow
- present
- Prior art date
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invención se relaciona con células facilitatorias hematopoyéticas de mamífero. En particular, se relaciona con el aislamiento, la caracterización y usos de las células facilitatorias hematopoyéticas. Las células facilitatorias de la presente invención se puede distinguir de las otras células de médula ósea conocidas mediante su morfología, fenotipo de superficie de célula y función in vivo. Cuando se co-administran con otras células de médula ósea incluyendo hemocitoblastos hematopoyéticos en un receptor, las células facilitatorias mejoran su injerto, sin actividades biológicas perjudiciales aparentes. Por lo tanto, las células facilitatorias pueden tener una amplia escala de aplicaciones, incluyendo, pero no quedando limitadas a reconstrucción hematopoyética mediante trasplante de médula ósea para el tratamiento de cánceres, anemias, autoinmunidad, inmunodeficiencia, infecciones virales y trastornos metabólicos, así como su uso potencial para facilitar el transplante de órgano sólido.The present invention relates to mammalian hematopoietic facilitator cells. In particular, it is related to the isolation, characterization and uses of hematopoietic facilitator cells. The facilitator cells of the present invention can be distinguished from other known bone marrow cells by their morphology, cell surface phenotype, and in vivo function. When co-administered with other bone marrow cells including hematopoietic hemocytoblasts in a receptor, the facilitating cells enhance their grafting, with no apparent detrimental biological activities. Therefore, facilitator cells can have a wide range of applications, including, but not limited to, hematopoietic reconstruction by bone marrow transplantation for the treatment of cancers, anemias, autoimmunity, immunodeficiency, viral infections, and metabolic disorders, as well as their potential use to facilitate solid organ transplantation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91198992A | 1992-07-10 | 1992-07-10 | |
US99654492A | 1992-12-24 | 1992-12-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9304187A true MX9304187A (en) | 1994-02-28 |
Family
ID=27129590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9304187A MX9304187A (en) | 1992-07-10 | 1993-07-12 | HEMATOPOYETIC FACILITATORY CELLS. |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN1058991C (en) |
IL (1) | IL106295A (en) |
MX (1) | MX9304187A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006047954A1 (en) * | 2004-11-04 | 2006-05-11 | Ziyi Cheng | The method of obtaining and applying the materials for autoantigen immunological recognition |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5061620A (en) * | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
-
1993
- 1993-07-09 IL IL10629593A patent/IL106295A/en not_active IP Right Cessation
- 1993-07-10 CN CN93116872A patent/CN1058991C/en not_active Expired - Lifetime
- 1993-07-12 MX MX9304187A patent/MX9304187A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1091955A (en) | 1994-09-14 |
IL106295A0 (en) | 1993-11-15 |
CN1058991C (en) | 2000-11-29 |
IL106295A (en) | 2001-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nakahara et al. | Culture‐expanded human periosteal‐derived cells exhibit osteochondral potential in vivo | |
Lazzeri et al. | Regenerative potential of embryonic renal multipotent progenitors in acute renal failure | |
Wakitani et al. | Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5‐azacytidine | |
Gotoh et al. | Immunological characteristics of purified pancreatic islet grafts | |
Nade et al. | Decalcified bone as a substrate for osteogenesis. An appraisal of the interrelation of bone and marrow in combined grafts | |
ATE365045T1 (en) | PRODUCTION OF SOFT AND BONE TISSUE USING PRECURSOR CELLS FROM MUSCLE, AS WELL AS ASSOCIATED COMPOSITIONS AND FORMS OF TREATMENT | |
US6607720B1 (en) | Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction | |
DK1019493T3 (en) | Preparation of hematopoietic cells from multipotent neural stem cells | |
BG94804A (en) | ISOLATES OF TRICHODERMA, FUNGICIDAL COMPOSITIONS CONTAINING THESE ISOLATES AND THEIR USE AGAINST V. SINEREA AND S. S. CLEROTIORUM | |
CA2390281A1 (en) | Hematopoietic differentiation of human embryonic stem cells | |
IT1260148B (en) | USE OF HYALURONIC ACID PREPARATIONS FOR THE FORMATION OF BONE TISSUE | |
BG96329A (en) | MODIFIED BIOLOGICAL MATERIAL | |
Ereskovsky et al. | The problem of germ layers in sponges (Porifera) and some issues concerning early metazoan evolution | |
HUS1900041I1 (en) | Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation | |
WO2002040640A3 (en) | Methods of using cd8+/tcr- facilitating cells (fc) for the engraftment of purified hematopoietic stem cells (hsc) | |
CA2653881A1 (en) | Methods of selecting stem cells and uses thereof | |
WO2001068814A3 (en) | Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same | |
MX9304187A (en) | HEMATOPOYETIC FACILITATORY CELLS. | |
DK0652943T3 (en) | Hematopoietic, promoting cells and their use | |
Rieck | Unexpected durability of PKH 26 staining on rat adipocytes | |
AU6949994A (en) | Animal model for hepatitis virus infection | |
Batten et al. | Immune response to stem cells and strategies to induce tolerance | |
Higashida et al. | Cytotoxic action of prostaglandin D2 on mouse neuroblastoma cells | |
Vigneau et al. | Stem cells and kidney injury | |
ES2039615T3 (en) | A PROCEDURE FOR THE PREPARATION OF NUCLEOSIDES. |